NCT05663879View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of ID120040002 in Healthy Volunteers

PHASE1UnknownINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

December 7, 2022

Primary Completion Date

July 31, 2023

Study Completion Date

July 31, 2023

Conditions
Healthy
Interventions
DRUG

ID120040002

Drug: ID120040002

DRUG

Compound-X

Drug: Compound-X

DRUG

Placebo comparator

Placebo comparator

Trial Locations (1)

03080

RECRUITING

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

IlDong Pharmaceutical Co Ltd

INDUSTRY

NCT05663879 - Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of ID120040002 in Healthy Volunteers | Biotech Hunter | Biotech Hunter